Bone growth into a ceramic-filled defect around an implant. The response to transforming growth factor beta1.
Synthetic bone substitutes provide an alternative to autograft but do not give equivalent clinical results. Their performance may be enhanced by adding osteogenic growth factors. In this study, TGFbeta1 was absorbed on to a carrier of beta tricalcium phosphate and Gelfoam and used to fill a defect around a tibial implant in a rat model of revision arthoplasty. We added 0.0, 0.02 microg, 0.1 microg or 1.0 microg of TGFbeta1 to the carrier and then implanted it around an hydroxyapatite-coated stainless-steel pin in the proximal tibia of rats. The tibiae were harvested at three, six or 26 weeks and the amount of bone formation and ceramic resorption were assessed. TGFbeta1 had no effect on the amount of bone in the defect, the amount of fluorescent label incorporated or the rate of mineral apposition. The growth factor did not significantly affect the amount of betaTCP remaining in the tissue at any of the time points.
Clarke
S A
SA
University of Cambridge, England, UK.
Brooks
R A
RA
Lee
P T H
PT
Rushton
N
N
D000818:Animals; D001846:Bone Development / Q000187:drug effects*; D001858:Bone Nails; D018786:Bone Substitutes; D002130:Calcium Phosphates; D020099:Coated Materials, Biocompatible; D017886:Durapatite; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013977:Tibia; D014025:Titanium; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D053773:Transforming Growth Factor beta1
D018786:Bone Substitutes; D002130:Calcium Phosphates; D020099:Coated Materials, Biocompatible; C508962:Tgfb1 protein, rat; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; C485817:beta-tricalcium phosphate; D017886:Durapatite; D014025:Titanium; C018392:tricalcium phosphate